University at Buffalo (UB)
Whether it's failure of science, lack of business development, or a conflict between management and the company's board of directors or investors, Dr. Christie addresses how biotech leaders make critical decisions and the effects on the team, the core science, and the intellectual property portfolio.
Julianna Fortain
Email: jellis9@buffalo.edu